Scientists use new examination for IBC

Scientists have found a better prognosis for the rare form of inflammatory breast cancer (IBC).

Researchers from the University of Texas studied 41 women between the ages of 25 and 71 who had been diagnosed with unilateral primary IBC, which is a rare but more aggressive form of breast cancer.

Each patient underwent a full-body fluorodeoxyglucose positron emission tomography combined with computed tomography (PET/CT) exam during the initial stages of the disease to identify the precise location and spread of the disease.

Homer Macapinlac, professor of nuclear medicine at the university's Anderson Cancer Centre, said PET/CT can give information on both the "primary disease site" and "disease involvement" throughout the body.

"The use of a whole-body modality such as PET/CT with its higher sensitivity, however, allows us to pinpoint metastasis in other parts of the body; for example, behind the clavicle - which can not be detected in a physical exam - or in the abdominal organs or pelvic lymph nodes," he added.

A new test called DyNeMo was recently revealed, which can predict with 80 per cent accuracy the chance a woman can recover from breast cancer.
ADNFCR-2094-ID-19006215-ADNFCR